Viridian Therapeutics, Inc.\DE (VRDN) Shares Issued (2014 - 2016)
Viridian Therapeutics, Inc.\DE's (VRDN) quarterly Shares Issued came in at $67695.0 in Q4 2016, up 60.78% year-on-year from $42104.0 in Q1 2016, and down 88.35% quarter-over-quarter from $580941.0 in Q3 2016.
Viridian Therapeutics, Inc.\DE (VRDN) Shares Issued (2014 - 2016) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Shares Issued history runs 3 years deep, the most recent figure standing at $67695.0 for Q4 2016.
- On a quarterly basis, Shares Issued rose 60.78% year-over-year to $67695.0 in Q4 2016; TTM through Dec 2016 was $67695.0, a 60.78% increase from a year earlier, with the FY2016 full-year figure at $67695.0, up 60.78% from the prior year.
- Shares Issued declined to $67695.0 in Q4 2016 per VRDN's latest filing, from $580941.0 in the prior quarter.
- Across five years, Shares Issued topped out at $673027.0 in Q3 2015 and bottomed at $42104.0 in Q4 2015.
- The 3-year median for Shares Issued is $179000.0 (2015), against an average of $341382.6.
- Across the five-year window, Shares Issued sank 72.3% in 2015 and surged 247.95% in 2016, its largest moves.
- Year by year, Shares Issued stood at $152000.0 in 2014, then sank by 72.3% to $42104.0 in 2015, then jumped by 60.78% to $67695.0 in 2016.
- Per Business Quant, the three latest VRDN Shares Issued figures stand at $67695.0 (Q4 2016), $580941.0 (Q3 2016), and $622837.0 (Q2 2016).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 88,604.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.44 Mn |
| 10 | Viridian Therapeutics, Inc.\DE | 631.55 Mn | 631.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 67,695.00 |
| Dec 31, 2016 | 67,695.00 |
| Sep 30, 2016 | 580,941.00 |
| Sep 30, 2016 | 580,941.00 |
| Jun 30, 2016 | 622,837.00 |
| Jun 30, 2016 | 622,837.00 |
| Mar 31, 2016 | 580,960.00 |
| Mar 31, 2016 | 580,960.00 |
| Dec 31, 2015 | 42,104.00 |
| Dec 31, 2015 | 42,104.00 |
| Sep 30, 2015 | 673,027.00 |
| Sep 30, 2015 | 673,027.00 |
| Jun 30, 2015 | 179,000.00 |
| Jun 30, 2015 | 179,000.00 |
| Mar 31, 2015 | 173,879.00 |
| Mar 31, 2015 | 173,879.00 |
| Dec 31, 2014 | 152,000.00 |
| Dec 31, 2014 | 152,000.00 |